ESTROGEN

ESTROGEN was reported 2911 times

ESTROGEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAROTID PULSE INCREASED 2 0.1053
1 BIOPSY BREAST ABNORMAL 5 0.0526
2 MALIGNANT BREAST LUMP REMOVAL 6 0.0448
3 THYROTOXIC PERIODIC PARALYSIS 4 0.0274
4 BLOOD ALDOSTERONE DECREASED 2 0.0263
5 BREAST RECONSTRUCTION 9 0.0239
6 PERSISTENT GENITAL AROUSAL DISORDER 4 0.0172
7 BREAST MICROCALCIFICATION 2 0.0167
8 CERVIX NEOPLASM 2 0.0146
9 BREAST INJURY 2 0.0123
10 CARNITINE DEFICIENCY 2 0.0117
11 OESTROGEN DEFICIENCY 3 0.0109
12 VULVOVAGINITIS 3 0.0102
13 BREAST OPERATION 8 0.0098
14 BIOPSY BREAST 3 0.0096
15 MASTECTOMY 15 0.0086
16 CERVICAL POLYP 3 0.0079
17 HYPOPARATHYROIDISM 6 0.0078
18 BLOOD CORTISOL INCREASED 2 0.0075
19 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
20 BONE FRAGMENTATION 4 0.0071
21 ENDOMETRIAL HYPERPLASIA 5 0.0062
22 CALCIUM DEFICIENCY 8 0.0062
23 ADMINISTRATION SITE BRUISE 2 0.0058
24 TRI-IODOTHYRONINE DECREASED 3 0.0057
25 BREAST HYPERPLASIA 2 0.0057
26 FIBROCYSTIC BREAST DISEASE 4 0.0054
27 ENDOMETRIAL THICKENING 3 0.0054
28 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 2 0.0051
29 PREMATURE MENOPAUSE 4 0.0043
30 FOREARM FRACTURE 3 0.0043
31 CERVICAL RADICULOPATHY 3 0.0042
32 ATROPHIC VULVOVAGINITIS 3 0.0041
33 CAPILLARY FRAGILITY 2 0.0039
34 BREAST CONSERVING SURGERY 2 0.0039
35 MENOPAUSAL SYMPTOMS 9 0.0039
36 UTERINE DISORDER 9 0.0039
37 CATAPLEXY 5 0.0035
38 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
39 ADENOMYOSIS 2 0.0034
40 PALATAL OEDEMA 4 0.0032
41 AMPUTATION 4 0.0032
42 NARCOLEPSY 6 0.0032
43 PELVIC DISCOMFORT 3 0.0032
44 ENDOMETRIOSIS 15 0.0031
45 ADNEXA UTERI PAIN 4 0.0031
46 VAGINAL DISORDER 3 0.0031
47 ULNA FRACTURE 3 0.0030
48 SKIN OEDEMA 3 0.0030
49 BLOOD OESTROGEN DECREASED 2 0.0028
50 APPLICATION SITE ULCER 2 0.0028
51 VULVOVAGINAL DRYNESS 9 0.0028
52 CEREBRAL VASOCONSTRICTION 2 0.0027
53 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
54 INAPPROPRIATE AFFECT 4 0.0025
55 BREAST CALCIFICATIONS 2 0.0025
56 NIGHT BLINDNESS 4 0.0025
57 BLADDER PROLAPSE 3 0.0025
58 LIMB MASS 5 0.0023
59 HORMONE LEVEL ABNORMAL 11 0.0023
60 TRICHORRHEXIS 6 0.0021
61 BREAST ENLARGEMENT 7 0.0021
62 ATYPICAL FEMUR FRACTURE 6 0.0021
63 CONNECTIVE TISSUE DISORDER 3 0.0021
64 HAIR DISORDER 17 0.0021
65 ANIMAL SCRATCH 2 0.0021
66 APPLICATION SITE BRUISE 2 0.0021
67 EARLY SATIETY 4 0.0021
68 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
69 ADHESION 3 0.0020
70 POSTMENOPAUSAL HAEMORRHAGE 5 0.0019
71 LIMB DEFORMITY 3 0.0019
72 BONE NEOPLASM 2 0.0019
73 PITUITARY TUMOUR BENIGN 3 0.0018
74 INVASIVE DUCTAL BREAST CARCINOMA 5 0.0018
75 VULVOVAGINAL DISCOMFORT 8 0.0018
76 MADAROSIS 21 0.0018
77 AORTIC DILATATION 2 0.0018
78 VITAMIN B12 DEFICIENCY 7 0.0017
79 HAIR TEXTURE ABNORMAL 23 0.0017
80 APPENDICECTOMY 6 0.0017
81 UTERINE POLYP 3 0.0017
82 LONG QT SYNDROME 4 0.0017
83 RADIUS FRACTURE 4 0.0017
84 UTERINE HAEMORRHAGE 7 0.0016
85 VULVOVAGINAL SWELLING 3 0.0016
86 UTERINE SPASM 3 0.0016
87 PSYCHOLOGICAL TRAUMA 14 0.0016
88 CARTILAGE INJURY 4 0.0016
89 HYSTERECTOMY 14 0.0016
90 APPLICATION SITE SCAR 2 0.0016
91 HAIR GROWTH ABNORMAL 11 0.0016
92 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
93 PANCREATIC CYST 3 0.0016
94 GINGIVAL RECESSION 3 0.0016
95 DRUG TITRATION ERROR 4 0.0015
96 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
97 NIPPLE PAIN 3 0.0015
98 CARBON DIOXIDE INCREASED 2 0.0015
99 APPLICATION SITE INFLAMMATION 2 0.0014
100 PRE-EXISTING CONDITION IMPROVED 9 0.0014
101 BREAST CANCER FEMALE 37 0.0014
102 VULVOVAGINAL PRURITUS 7 0.0014
103 SPINAL OSTEOARTHRITIS 12 0.0014
104 MIDDLE EAR EFFUSION 3 0.0014
105 LIGAMENT RUPTURE 6 0.0014
106 SPINAL COLUMN INJURY 3 0.0013
107 AUTOIMMUNE THYROIDITIS 5 0.0013
108 VULVOVAGINAL BURNING SENSATION 8 0.0013
109 DYSPAREUNIA 6 0.0013
110 SCOLIOSIS 8 0.0013
111 HAIR COLOUR CHANGES 16 0.0013
112 NAIL DISCOLOURATION 5 0.0013
113 OSTEOPENIA 19 0.0013
114 HOMICIDAL IDEATION 5 0.0012
115 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
116 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
117 APPLICATION SITE SWELLING 6 0.0012
118 EYELID IRRITATION 3 0.0012
119 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
120 CERVICAL SPINAL STENOSIS 2 0.0012
121 LYMPHOEDEMA 8 0.0012
122 TACHYPHRENIA 4 0.0012
123 BONE DISORDER 21 0.0012
124 ERYTHEMA NODOSUM 4 0.0011
125 FACIAL PARESIS 4 0.0011
126 VITAMIN D DEFICIENCY 11 0.0011
127 FIBRIN D DIMER INCREASED 4 0.0011
128 CARDIAC ABLATION 2 0.0011
129 UTERINE LEIOMYOMA 8 0.0011
130 PARADOXICAL DRUG REACTION 4 0.0011
131 TENDON INJURY 4 0.0011
132 AURA 2 0.0011
133 PRODUCT FORMULATION ISSUE 7 0.0011
134 FIBULA FRACTURE 3 0.0010
135 GINGIVAL DISORDER 4 0.0010
136 HYPERTONIC BLADDER 3 0.0010
137 ATROPHY 2 0.0010
138 EPIGASTRIC DISCOMFORT 4 0.0010
139 FOOT OPERATION 5 0.0010
140 CANDIDIASIS 4 0.0010
141 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
142 VAGINAL DISCHARGE 10 0.0010
143 BREAST DISORDER 2 0.0010
144 INTRACARDIAC THROMBUS 3 0.0010
145 CHEST INJURY 2 0.0010
146 THYROID FUNCTION TEST ABNORMAL 4 0.0010
147 NASAL DRYNESS 6 0.0010
148 BLOOD TESTOSTERONE INCREASED 2 0.0009
149 APPLICATION SITE SCAB 2 0.0009
150 LYMPHOCYTE COUNT INCREASED 3 0.0009
151 WRIST FRACTURE 11 0.0009
152 CERVICAL DYSPLASIA 2 0.0009
153 HOT FLUSH 69 0.0009
154 MULTIPLE FRACTURES 15 0.0009
155 GASTROINTESTINAL PAIN 10 0.0009
156 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
157 THERAPEUTIC AGENT TOXICITY 3 0.0009
158 APPLICATION SITE URTICARIA 2 0.0009
159 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
160 EYELID PTOSIS 9 0.0009
161 NASAL DISCOMFORT 7 0.0009
162 SKIN ATROPHY 5 0.0009
163 FEELING OF DESPAIR 4 0.0009
164 DRUG ADMINISTERED AT INAPPROPRIATE SITE 9 0.0009
165 WRONG TECHNIQUE IN DRUG USAGE PROCESS 31 0.0009
166 OSTEOPOROSIS 35 0.0009
167 LACERATION 8 0.0008
168 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
169 PHARYNGEAL OEDEMA 13 0.0008
170 FOOT FRACTURE 16 0.0008
171 EMBOLISM 7 0.0008
172 BODY HEIGHT DECREASED 9 0.0008
173 ANKLE FRACTURE 13 0.0008
174 VULVOVAGINAL PAIN 4 0.0008
175 BRONCHITIS CHRONIC 2 0.0008
176 VITREOUS FLOATERS 8 0.0008
177 MENISCUS INJURY 5 0.0008
178 HYPERACUSIS 3 0.0008
179 OVARIAN CYST 8 0.0008
180 VEIN DISORDER 4 0.0008
181 PAROSMIA 6 0.0008
182 PARANASAL SINUS DISCOMFORT 3 0.0008
183 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
184 FEELING JITTERY 15 0.0008
185 PARANASAL SINUS HYPERSECRETION 3 0.0008
186 FIBROMYALGIA 19 0.0008
187 AORTIC ARTERIOSCLEROSIS 2 0.0008
188 TENDONITIS 12 0.0008
189 CONCUSSION 6 0.0008
190 CARDIAC FLUTTER 5 0.0008
191 RESTLESS LEGS SYNDROME 14 0.0008
192 EXOSTOSIS 7 0.0008
193 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
194 SOMNAMBULISM 5 0.0008
195 CYSTITIS 24 0.0008
196 FOREIGN BODY 3 0.0007
197 ALCOHOL ABUSE 2 0.0007
198 ABDOMINAL MASS 2 0.0007
199 COLITIS ISCHAEMIC 5 0.0007
200 ERYTHEMA OF EYELID 4 0.0007
201 CHONDROPATHY 2 0.0007
202 TRIGGER FINGER 3 0.0007
203 GOITRE 3 0.0007
204 SPINAL STENOSIS 3 0.0007
205 PELVIC PAIN 13 0.0007
206 ANGIOPATHY 4 0.0007
207 SLEEP TERROR 3 0.0007
208 APPLICATION SITE REACTION 5 0.0007
209 AORTIC VALVE INCOMPETENCE 3 0.0007
210 ROTATOR CUFF SYNDROME 9 0.0007
211 CHOLECYSTECTOMY 8 0.0007
212 CARDIAC VALVE DISEASE 4 0.0007
213 PARALYSIS 10 0.0007
214 TENSION HEADACHE 3 0.0007
215 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
216 HYPERTHYROIDISM 10 0.0007
217 DRY THROAT 7 0.0007
218 BILIARY COLIC 2 0.0007
219 TONGUE DISCOLOURATION 3 0.0007
220 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
221 PURPURA 6 0.0007
222 ENERGY INCREASED 4 0.0007
223 PSYCHIATRIC SYMPTOM 5 0.0007
224 BREAST TENDERNESS 5 0.0007
225 ECONOMIC PROBLEM 10 0.0007
226 INJECTION SITE PAPULE 3 0.0007
227 POOR QUALITY SLEEP 14 0.0006
228 THYROID DISORDER 10 0.0006
229 PIGMENTATION DISORDER 4 0.0006
230 NEPHROGENIC ANAEMIA 3 0.0006
231 SCAR 11 0.0006
232 DRY EYE 32 0.0006
233 MUSCULOSKELETAL DISCOMFORT 11 0.0006
234 VAGINAL INFECTION 3 0.0006
235 OSTEOARTHRITIS 27 0.0006
236 AFFECTIVE DISORDER 5 0.0006
237 SKIN ABRASION 3 0.0006
238 SPINAL DISORDER 6 0.0006
239 ABDOMINAL ADHESIONS 2 0.0006
240 CRYING 23 0.0006
241 MUSCLE ATROPHY 8 0.0006
242 NERVE INJURY 7 0.0006
243 FOREIGN BODY SENSATION IN EYES 4 0.0006
244 RASH PAPULAR 14 0.0006
245 FAECAL INCONTINENCE 3 0.0006
246 INTENTIONAL DRUG MISUSE 13 0.0006
247 ERUCTATION 12 0.0006
248 APPLICATION SITE VESICLES 4 0.0006
249 GALLBLADDER DISORDER 11 0.0006
250 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
251 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
252 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
253 TENDON DISORDER 4 0.0006
254 COELIAC DISEASE 6 0.0006
255 ARTHRITIS 48 0.0006
256 TINNITUS 28 0.0006
257 TOOTHACHE 11 0.0006
258 INFLAMMATORY MARKER INCREASED 3 0.0006
259 SPINAL COMPRESSION FRACTURE 5 0.0006
260 ABDOMINAL TENDERNESS 3 0.0006
261 EYELID OEDEMA 7 0.0006
262 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
263 HYPOTHYROIDISM 19 0.0006
264 DRUG TOLERANCE 3 0.0006
265 POSTOPERATIVE WOUND INFECTION 4 0.0006
266 APPLICATION SITE PAIN 13 0.0006
267 ABNORMAL LOSS OF WEIGHT 4 0.0006
268 FEMORAL NECK FRACTURE 3 0.0006
269 VITAMIN D DECREASED 5 0.0006
270 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
271 PERIPHERAL VASCULAR DISORDER 3 0.0006
272 CERVICAL VERTEBRAL FRACTURE 2 0.0006
273 BREAST CANCER 54 0.0006
274 VAGINAL HAEMORRHAGE 25 0.0006
275 HYPOMAGNESAEMIA 8 0.0006
276 MALABSORPTION 3 0.0006
277 AORTIC STENOSIS 2 0.0006
278 CAROTID ARTERY STENOSIS 2 0.0006
279 TENDON RUPTURE 7 0.0006
280 ANORECTAL DISCOMFORT 3 0.0006
281 THERMAL BURN 4 0.0006
282 RESPIRATORY RATE INCREASED 5 0.0006
283 JOINT INJURY 12 0.0006
284 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
285 NIGHT SWEATS 18 0.0006
286 IMPAIRED QUALITY OF LIFE 8 0.0006
287 GINGIVITIS 3 0.0006
288 ANAL INCONTINENCE 5 0.0006
289 PARAESTHESIA ORAL 8 0.0006
290 BONE LESION 2 0.0006
291 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
292 TONGUE DISORDER 4 0.0006
293 SKIN LACERATION 6 0.0006
294 JAW DISORDER 3 0.0005
295 INJECTION SITE NODULE 6 0.0005
296 ALOPECIA 106 0.0005
297 FEELING COLD 15 0.0005
298 NECK PAIN 30 0.0005
299 NERVOUSNESS 28 0.0005
300 MIDDLE INSOMNIA 10 0.0005
301 BONE DENSITY ABNORMAL 2 0.0005
302 MIGRAINE 51 0.0005
303 FLANK PAIN 5 0.0005
304 EYE INFECTION 6 0.0005
305 SQUAMOUS CELL CARCINOMA 5 0.0005
306 ANKYLOSING SPONDYLITIS 7 0.0005
307 HYPERHIDROSIS 68 0.0005
308 CLAVICLE FRACTURE 2 0.0005
309 HYPERVENTILATION 3 0.0005
310 BLOOD CHOLESTEROL INCREASED 24 0.0005
311 IMPAIRED WORK ABILITY 11 0.0005
312 SPLENOMEGALY 6 0.0005
313 GASTROINTESTINAL INFLAMMATION 4 0.0005
314 TORSADE DE POINTES 4 0.0005
315 PERIPHERAL COLDNESS 7 0.0005
316 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
317 APPLICATION SITE RASH 7 0.0005
318 LYMPHADENOPATHY 18 0.0005
319 ABNORMAL DREAMS 14 0.0005
320 SINUS HEADACHE 3 0.0005
321 CHOLECYSTITIS 6 0.0005
322 UPPER LIMB FRACTURE 10 0.0005
323 COORDINATION ABNORMAL 7 0.0005
324 CEREBRAL ATROPHY 2 0.0005
325 APHONIA 7 0.0005
326 ARTERIOSPASM CORONARY 2 0.0005
327 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
328 MUSCULOSKELETAL PAIN 26 0.0005
329 RHINITIS 4 0.0005
330 APPLICATION SITE ERYTHEMA 13 0.0005
331 INJECTION SITE VESICLES 3 0.0005
332 BURSITIS 6 0.0005
333 PAIN IN JAW 14 0.0005
334 FEELING HOT 30 0.0005
335 FEELING ABNORMAL 117 0.0005
336 EUPHORIC MOOD 5 0.0005
337 EAR DISCOMFORT 5 0.0005
338 HYPERAESTHESIA 4 0.0005
339 EMOTIONAL DISORDER 15 0.0005
340 APPLICATION SITE EXFOLIATION 2 0.0005
341 INSOMNIA 129 0.0005
342 CYST 6 0.0005
343 FEAR 13 0.0005
344 THINKING ABNORMAL 9 0.0005
345 EYE DISCHARGE 5 0.0005
346 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
347 TENDERNESS 5 0.0005
348 SECRETION DISCHARGE 6 0.0005
349 PALPITATIONS 56 0.0005
350 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
351 PRODUCT ODOUR ABNORMAL 5 0.0005
352 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
353 PHOTOPSIA 3 0.0005
354 JOINT DISLOCATION 5 0.0005
355 URINARY INCONTINENCE 14 0.0005
356 MOOD SWINGS 15 0.0005
357 BREAST PAIN 5 0.0005
358 IRRITABLE BOWEL SYNDROME 10 0.0005
359 HEREDITARY ANGIOEDEMA 5 0.0005
360 ABNORMAL SENSATION IN EYE 2 0.0005
361 HYPERPROLACTINAEMIA 3 0.0005
362 PRURITUS GENERALISED 10 0.0005
363 PLATELET COUNT INCREASED 6 0.0005
364 LOCAL SWELLING 8 0.0005
365 MENORRHAGIA 9 0.0005
366 POLYP 3 0.0005
367 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
368 DRY MOUTH 37 0.0005
369 PULMONARY CONGESTION 6 0.0005
370 HYPERSOMNIA 13 0.0005
371 LIMB DISCOMFORT 14 0.0005
372 INTESTINAL OBSTRUCTION 17 0.0005
373 POST-TRAUMATIC STRESS DISORDER 3 0.0004
374 JOINT RANGE OF MOTION DECREASED 6 0.0004
375 FISTULA 5 0.0004
376 BONE PAIN 26 0.0004
377 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
378 PANIC ATTACK 16 0.0004
379 ECCHYMOSIS 3 0.0004
380 RIB FRACTURE 9 0.0004
381 INJECTION SITE WARMTH 9 0.0004
382 CORONARY ARTERY OCCLUSION 6 0.0004
383 RETINAL DETACHMENT 4 0.0004
384 PRODUCT QUALITY ISSUE 59 0.0004
385 HEART RATE INCREASED 43 0.0004
386 OVARIAN CANCER 4 0.0004
387 WEIGHT INCREASED 97 0.0004
388 IRRITABILITY 26 0.0004
389 FORMICATION 3 0.0004
390 EXTRASYSTOLES 3 0.0004
391 DERMATITIS 9 0.0004
392 MASS 6 0.0004
393 CARPAL TUNNEL SYNDROME 6 0.0004
394 PHOTOPHOBIA 8 0.0004
395 ANXIETY 121 0.0004
396 STAPHYLOCOCCAL INFECTION 14 0.0004
397 VENTRICULAR TACHYCARDIA 7 0.0004
398 HAND FRACTURE 3 0.0004
399 HYPOCALCAEMIA 8 0.0004
400 DEPRESSION 96 0.0004
401 PRODUCT ADHESION ISSUE 15 0.0004
402 CATARACT 25 0.0004
403 LOWER LIMB FRACTURE 8 0.0004
404 MUSCLE SPASMS 76 0.0004
405 ANGER 14 0.0004
406 ATELECTASIS 4 0.0004
407 FAECES SOFT 3 0.0004
408 MAJOR DEPRESSION 3 0.0004
409 OROPHARYNGEAL PAIN 38 0.0004
410 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
411 GASTRIC DISORDER 14 0.0004
412 FREQUENT BOWEL MOVEMENTS 11 0.0004
413 BLINDNESS TRANSIENT 3 0.0004
414 APPLICATION SITE BURN 2 0.0004
415 CEREBRAL DISORDER 3 0.0004
416 LIGAMENT SPRAIN 4 0.0004
417 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
418 EMBEDDED DEVICE 4 0.0004
419 FLUSHING 41 0.0004
420 EYE SWELLING 15 0.0004
421 BONE LOSS 6 0.0004
422 PRODUCT PHYSICAL ISSUE 8 0.0004
423 EMPHYSEMA 4 0.0004
424 CHOLELITHIASIS 13 0.0004
425 PARAESTHESIA 62 0.0004
426 VISION BLURRED 54 0.0004
427 TOOTH ABSCESS 4 0.0004
428 SUBARACHNOID HAEMORRHAGE 4 0.0004
429 DISSOCIATION 3 0.0004
430 PROCEDURAL COMPLICATION 3 0.0004
431 PRODUCT PREPARATION ERROR 8 0.0004
432 DISTURBANCE IN ATTENTION 21 0.0004
433 TEMPERATURE INTOLERANCE 4 0.0004
434 BACK PAIN 90 0.0004
435 APHTHOUS ULCER 3 0.0004
436 HIATUS HERNIA 5 0.0004
437 TREMOR 64 0.0004
438 BASAL CELL CARCINOMA 6 0.0004
439 SWOLLEN TONGUE 12 0.0004
440 MULTIPLE ALLERGIES 3 0.0004
441 RESTLESSNESS 14 0.0004
442 FOLLICULITIS 4 0.0004
443 CATATONIA 2 0.0004
444 BLOOD PRESSURE INCREASED 58 0.0004
445 RENAL PAIN 4 0.0004
446 MUSCULOSKELETAL STIFFNESS 33 0.0004
447 SCIATICA 6 0.0004
448 NIGHTMARE 13 0.0004
449 UTERINE CANCER 3 0.0004
450 ABDOMINAL DISTENSION 39 0.0004
451 INJECTION SITE PRURITUS 25 0.0004
452 QUALITY OF LIFE DECREASED 5 0.0004
453 SENSORY LOSS 3 0.0004
454 FRUSTRATION TOLERANCE DECREASED 3 0.0004
455 BRUXISM 2 0.0004
456 DECREASED ACTIVITY 4 0.0004
457 SINUS CONGESTION 5 0.0004
458 THROAT TIGHTNESS 10 0.0004
459 CHEILITIS 2 0.0004
460 BACK DISORDER 6 0.0004
461 FAECES DISCOLOURED 8 0.0004
462 POST PROCEDURAL INFECTION 3 0.0004
463 BLOOD URINE PRESENT 7 0.0004
464 HYPOKALAEMIA 17 0.0004
465 BACK INJURY 4 0.0004
466 PULMONARY THROMBOSIS 4 0.0004
467 POLYURIA 3 0.0004
468 GINGIVAL BLEEDING 5 0.0004
469 WOUND INFECTION 4 0.0004
470 BRONCHITIS 27 0.0004
471 PRODUCT SUBSTITUTION ISSUE 21 0.0004
472 POST PROCEDURAL COMPLICATION 7 0.0004
473 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
474 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
475 TOOTH DISORDER 8 0.0004
476 POLLAKIURIA 15 0.0004
477 ORAL HERPES 7 0.0004
478 OCULAR HYPERAEMIA 17 0.0004
479 CHROMATURIA 8 0.0004
480 HEART RATE IRREGULAR 8 0.0004
481 COLECTOMY 2 0.0004
482 REBOUND EFFECT 4 0.0004
483 AMNESIA 23 0.0004
484 SINUS DISORDER 7 0.0004
485 DISORIENTATION 14 0.0004
486 FLATULENCE 20 0.0004
487 IMPAIRED DRIVING ABILITY 4 0.0004
488 PARANOIA 6 0.0003
489 BLOOD MAGNESIUM DECREASED 3 0.0003
490 MUSCLE STRAIN 3 0.0003
491 CARDIAC MURMUR 3 0.0003
492 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
493 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
494 SKIN SWELLING 3 0.0003
495 ANOSMIA 5 0.0003
496 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
497 CONTUSION 33 0.0003
498 COGNITIVE DISORDER 16 0.0003
499 GASTRITIS 9 0.0003
500 ARTHROPATHY 19 0.0003
501 CHEST DISCOMFORT 35 0.0003
502 SEXUAL DYSFUNCTION 4 0.0003
503 HEAD DISCOMFORT 6 0.0003
504 SKIN HAEMORRHAGE 5 0.0003
505 EYE PAIN 19 0.0003
506 WRONG DRUG ADMINISTERED 3 0.0003
507 FACIAL PAIN 3 0.0003
508 PULMONARY MASS 5 0.0003
509 CARDIAC PACEMAKER INSERTION 2 0.0003
510 HEADACHE 210 0.0003
511 HAEMORRHAGE INTRACRANIAL 5 0.0003
512 DRUG EFFECT DECREASED 18 0.0003
513 WITHDRAWAL SYNDROME 14 0.0003
514 HYPOAESTHESIA ORAL 5 0.0003
515 LACRIMATION INCREASED 10 0.0003
516 LIP DRY 3 0.0003
517 LETHARGY 19 0.0003
518 FUNGAL INFECTION 11 0.0003
519 MOOD ALTERED 9 0.0003
520 CHRONIC KIDNEY DISEASE 25 0.0003
521 EATING DISORDER 7 0.0003
522 DRUG DISPENSING ERROR 5 0.0003
523 INJECTION SITE URTICARIA 8 0.0003
524 INCREASED TENDENCY TO BRUISE 3 0.0003
525 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
526 DYSURIA 12 0.0003
527 DYSPEPSIA 32 0.0003
528 NERVE COMPRESSION 3 0.0003
529 DIVERTICULITIS 9 0.0003
530 CHILLS 38 0.0003
531 BALANCE DISORDER 28 0.0003
532 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
533 MUSCULOSKELETAL CHEST PAIN 5 0.0003
534 PERSONALITY CHANGE 3 0.0003
535 INJECTION SITE ERYTHEMA 40 0.0003
536 HEPATIC STEATOSIS 6 0.0003
537 TOOTH EXTRACTION 4 0.0003
538 NEPHROPATHY 3 0.0003
539 ARTERIOSCLEROSIS 3 0.0003
540 BLEPHAROSPASM 2 0.0003
541 SPUTUM DISCOLOURED 3 0.0003
542 SLEEP APNOEA SYNDROME 6 0.0003
543 INJECTION SITE BRUISING 25 0.0003
544 HEART RATE DECREASED 11 0.0003
545 INTRAOCULAR PRESSURE INCREASED 4 0.0003
546 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
547 AFFECT LABILITY 3 0.0003
548 MOVEMENT DISORDER 10 0.0003
549 GENITAL HAEMORRHAGE 4 0.0003
550 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
551 DYSGEUSIA 23 0.0003
552 MUSCLE TIGHTNESS 5 0.0003
553 EAR PAIN 6 0.0003
554 HEPATIC ENZYME INCREASED 21 0.0003
555 ARTHRALGIA 128 0.0003
556 DYSPHONIA 18 0.0003
557 HAEMORRHOIDS 6 0.0003
558 NODULE 4 0.0003
559 BRADYPHRENIA 2 0.0003
560 SUICIDAL IDEATION 28 0.0003
561 KNEE OPERATION 3 0.0003
562 DIZZINESS 152 0.0003
563 IMPAIRED HEALING 10 0.0003
564 INCORRECT PRODUCT STORAGE 4 0.0003
565 TOOTH INFECTION 4 0.0003
566 PHOTOSENSITIVITY REACTION 5 0.0003
567 CONSTIPATION 66 0.0003
568 SINUSITIS 31 0.0003
569 BLADDER DISORDER 3 0.0003
570 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
571 DYSMENORRHOEA 4 0.0003
572 VISUAL ACUITY REDUCED 10 0.0003
573 WEIGHT DECREASED 84 0.0003
574 EXPIRED PRODUCT ADMINISTERED 10 0.0003
575 EYE HAEMORRHAGE 4 0.0003
576 PAIN 184 0.0003
577 BREAST MASS 2 0.0003
578 PAIN OF SKIN 8 0.0003
579 HYPOTHERMIA 3 0.0003
580 PRODUCT TASTE ABNORMAL 4 0.0003
581 EYE IRRITATION 17 0.0003
582 PAIN IN EXTREMITY 87 0.0003
583 RASH PRURITIC 16 0.0003
584 HYPOAESTHESIA 44 0.0003
585 METRORRHAGIA 5 0.0003
586 BLOOD TESTOSTERONE DECREASED 2 0.0003
587 SWELLING FACE 19 0.0003
588 MEMORY IMPAIRMENT 40 0.0003
589 DRUG DOSE OMISSION 48 0.0003
590 FATIGUE 226 0.0003
591 TOOTH LOSS 6 0.0003
592 NASAL CONGESTION 17 0.0003
593 VENTRICULAR EXTRASYSTOLES 3 0.0003
594 PROCEDURAL PAIN 8 0.0003
595 MYALGIA 49 0.0003
596 PRESYNCOPE 7 0.0003
597 BONE DENSITY DECREASED 9 0.0003
598 HUNGER 4 0.0003
599 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
600 SCRATCH 3 0.0003
601 PULMONARY EMBOLISM 27 0.0003
602 INCONTINENCE 3 0.0003
603 DEPRESSED MOOD 15 0.0003
604 BLINDNESS UNILATERAL 4 0.0003
605 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
606 SINUS TACHYCARDIA 4 0.0003
607 MUSCULAR WEAKNESS 32 0.0003
608 NAUSEA 222 0.0003
609 INFLUENZA LIKE ILLNESS 23 0.0003
610 BREAST CANCER METASTATIC 3 0.0003
611 VERTIGO 17 0.0003
612 BIPOLAR DISORDER 3 0.0003
613 DYSSTASIA 8 0.0003
614 PERIPHERAL SWELLING 42 0.0003
615 TOOTH FRACTURE 3 0.0003
616 DENTAL CARIES 3 0.0003
617 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
618 FOOT DEFORMITY 3 0.0003
619 CARDIOMYOPATHY 4 0.0003
620 INJECTION SITE MASS 10 0.0003
621 ARTHROPOD BITE 2 0.0003
622 SKIN DISORDER 9 0.0003
623 MALNUTRITION 3 0.0003
624 DEAFNESS 7 0.0003
625 SKIN INFECTION 3 0.0003
626 OCULAR DISCOMFORT 3 0.0003
627 SPEECH DISORDER 14 0.0003
628 BLISTER 15 0.0003
629 MITRAL VALVE INCOMPETENCE 3 0.0003
630 APPLICATION SITE PRURITUS 6 0.0003
631 BLOOD COUNT ABNORMAL 4 0.0003
632 URINARY TRACT INFECTION 45 0.0003
633 DERMATITIS CONTACT 3 0.0003
634 RHINORRHOEA 17 0.0003
635 ROAD TRAFFIC ACCIDENT 11 0.0003
636 INTENTIONAL PRODUCT MISUSE 23 0.0003
637 ABDOMINAL DISCOMFORT 44 0.0003
638 CONVULSION 15 0.0003
639 ABDOMINAL PAIN 61 0.0003
640 INCREASED APPETITE 5 0.0003
641 BOWEL MOVEMENT IRREGULARITY 2 0.0003
642 SKIN DISCOLOURATION 12 0.0003
643 ATRIOVENTRICULAR BLOCK 2 0.0003
644 VASCULITIS 3 0.0003
645 LUNG INFECTION 4 0.0003
646 BURNING SENSATION 18 0.0003
647 SWELLING 24 0.0003
648 CHOKING 5 0.0003
649 ASTHENIA 96 0.0003
650 HAEMATOCHEZIA 14 0.0003
651 BLOOD IRON DECREASED 3 0.0003
652 ABDOMINAL PAIN UPPER 52 0.0003
653 PNEUMOTHORAX 4 0.0003
654 HAEMATOCRIT DECREASED 5 0.0003
655 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
656 OBESITY 4 0.0003
657 INJECTION SITE PAIN 77 0.0003
658 MOBILITY DECREASED 18 0.0003
659 INCORRECT DOSE ADMINISTERED 57 0.0002
660 FALL 83 0.0002
661 HIP FRACTURE 8 0.0002
662 HEPATITIS C 3 0.0002
663 CHEST PAIN 46 0.0002
664 SOMNOLENCE 50 0.0002
665 DRUG EFFECT INCOMPLETE 9 0.0002
666 MENTAL IMPAIRMENT 6 0.0002
667 PRODUCT ADMINISTRATION ERROR 5 0.0002
668 ADRENAL INSUFFICIENCY 3 0.0002
669 PSORIATIC ARTHROPATHY 10 0.0002
670 DYSKINESIA 10 0.0002
671 NO THERAPEUTIC RESPONSE 3 0.0002
672 LIVER INJURY 6 0.0002
673 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
674 CARDIOMEGALY 3 0.0002
675 SPINAL OPERATION 3 0.0002
676 EYE DISORDER 8 0.0002
677 GENERALISED OEDEMA 3 0.0002
678 DYSPHAGIA 23 0.0002
679 CONFUSIONAL STATE 39 0.0002
680 APPLICATION SITE IRRITATION 3 0.0002
681 GAIT DISTURBANCE 46 0.0002
682 COAGULOPATHY 4 0.0002
683 PRODUCT USE ISSUE 45 0.0002
684 MALAISE 105 0.0002
685 BLOOD UREA INCREASED 4 0.0002
686 SURGERY 14 0.0002
687 UNEVALUABLE EVENT 18 0.0002
688 INJECTION SITE HAEMORRHAGE 19 0.0002
689 ACNE 18 0.0002
690 SKIN BURNING SENSATION 17 0.0002
691 ABDOMINAL PAIN LOWER 6 0.0002
692 CANDIDA INFECTION 4 0.0002
693 CARDIOVASCULAR DISORDER 6 0.0002
694 FLUID RETENTION 12 0.0002
695 RENAL INJURY 7 0.0002
696 INJECTION SITE SWELLING 18 0.0002
697 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
698 URTICARIA 39 0.0002
699 DEHYDRATION 31 0.0002
700 HYPOACUSIS 10 0.0002
701 JOINT SWELLING 28 0.0002
702 AGITATION 17 0.0002
703 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
704 DEEP VEIN THROMBOSIS 15 0.0002
705 SYNCOPE 23 0.0002
706 MENTAL DISORDER 10 0.0002
707 PRODUCT DOSE OMISSION 15 0.0002
708 RASH MACULAR 8 0.0002
709 JOINT STIFFNESS 6 0.0002
710 BEDRIDDEN 3 0.0002
711 INJECTION SITE RASH 7 0.0002
712 DRUG WITHDRAWAL SYNDROME 20 0.0002
713 COLD SWEAT 4 0.0002
714 HERPES ZOSTER 13 0.0002
715 EAR INFECTION 6 0.0002
716 MALIGNANT MELANOMA 3 0.0002
717 THIRST 4 0.0002
718 ORAL PAIN 5 0.0002
719 GOUT 4 0.0002
720 PANCREATITIS ACUTE 5 0.0002
721 HYPERTENSION 47 0.0002
722 DIARRHOEA 143 0.0002
723 OEDEMA 12 0.0002
724 VOMITING 104 0.0002
725 COUGH 62 0.0002
726 LIMB INJURY 6 0.0002
727 IMPAIRED GASTRIC EMPTYING 3 0.0002
728 END STAGE RENAL DISEASE 4 0.0002
729 DYSPNOEA 124 0.0002
730 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
731 NEPHROLITHIASIS 10 0.0002
732 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
733 MUSCLE TWITCHING 5 0.0002
734 ORAL DISCOMFORT 3 0.0002
735 CONJUNCTIVITIS 4 0.0002
736 APPENDICITIS 2 0.0002
737 BLOOD TEST ABNORMAL 3 0.0002
738 PRURITUS 82 0.0002
739 INFLAMMATION 11 0.0002
740 TARDIVE DYSKINESIA 6 0.0002
741 DYSARTHRIA 8 0.0002
742 DYSPNOEA EXERTIONAL 8 0.0002
743 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 43 0.0002
744 FRACTURE 4 0.0002
745 LOSS OF CONSCIOUSNESS 27 0.0002
746 GASTRIC ULCER 4 0.0002
747 MUSCULOSKELETAL DISORDER 4 0.0002
748 GAIT INABILITY 7 0.0002
749 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
750 BLOOD PRESSURE FLUCTUATION 5 0.0002
751 DRUG PRESCRIBING ERROR 4 0.0002
752 GLAUCOMA 4 0.0002
753 PRESCRIBED OVERDOSE 4 0.0002
754 DYSTONIA 4 0.0002
755 NEURALGIA 5 0.0002
756 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
757 OEDEMA PERIPHERAL 25 0.0002
758 SKIN FISSURES 4 0.0002
759 ASCITES 6 0.0002
760 INJECTION SITE REACTION 14 0.0002
761 ABNORMAL BEHAVIOUR 8 0.0002
762 COLITIS ULCERATIVE 9 0.0002
763 NASOPHARYNGITIS 37 0.0002
764 EPISTAXIS 15 0.0002
765 AGEUSIA 5 0.0002
766 SPINAL FRACTURE 4 0.0002
767 BRAIN INJURY 2 0.0002
768 SLEEP DISORDER 14 0.0002
769 MEDICATION ERROR 11 0.0002
770 DRUG INEFFECTIVE 260 0.0002
771 INFLUENZA 22 0.0002
772 HIP ARTHROPLASTY 3 0.0002
773 DRUG ADMINISTRATION ERROR 6 0.0002
774 HYPERSENSITIVITY 36 0.0002
775 ANAPHYLACTIC SHOCK 5 0.0002
776 DECREASED APPETITE 45 0.0002
777 FEMUR FRACTURE 6 0.0002
778 HAEMATOMA 5 0.0002
779 CONDITION AGGRAVATED 58 0.0002
780 GASTROINTESTINAL DISORDER 17 0.0002
781 HEAD INJURY 6 0.0002
782 DISEASE RECURRENCE 9 0.0002
783 RESPIRATORY TRACT CONGESTION 3 0.0002
784 ULCER 3 0.0002
785 PRODUCTIVE COUGH 9 0.0002
786 PYREXIA 65 0.0002
787 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
788 LIVER FUNCTION TEST INCREASED 4 0.0002
789 RECTAL HAEMORRHAGE 8 0.0002
790 JAUNDICE 5 0.0002
791 SKIN CANCER 4 0.0002
792 BLOOD BILIRUBIN INCREASED 5 0.0002
793 INJURY 13 0.0002
794 BLOOD POTASSIUM INCREASED 3 0.0002
795 RASH 80 0.0002
796 ACUTE KIDNEY INJURY 28 0.0002
797 METASTASES TO BONE 3 0.0002
798 ASPIRATION 2 0.0002
799 MANIA 3 0.0002
800 EMOTIONAL DISTRESS 22 0.0002
801 RENAL FAILURE 24 0.0002
802 BLOOD PRESSURE DECREASED 12 0.0002
803 LIP SWELLING 6 0.0002
804 OFF LABEL USE 157 0.0002
805 NEUROPATHY PERIPHERAL 17 0.0002
806 DEVICE ISSUE 16 0.0002
807 SNEEZING 4 0.0002
808 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
809 THROAT IRRITATION 8 0.0002
810 ADVERSE DRUG REACTION 16 0.0002
811 VISUAL IMPAIRMENT 22 0.0002
812 RHEUMATOID ARTHRITIS 20 0.0002
813 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
814 RED BLOOD CELL COUNT DECREASED 5 0.0002
815 THROMBOSIS 14 0.0002
816 DRY SKIN 23 0.0002
817 MYOCARDIAL INFARCTION 30 0.0002
818 SYRINGE ISSUE 3 0.0002
819 AMENORRHOEA 3 0.0002
820 CARDIAC DISORDER 16 0.0002
821 ACUTE MYOCARDIAL INFARCTION 5 0.0002
822 LABORATORY TEST ABNORMAL 5 0.0002
823 ISCHAEMIC STROKE 3 0.0002
824 ACCIDENT 2 0.0002
825 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
826 SYNOVITIS 3 0.0002
827 BLOOD POTASSIUM DECREASED 5 0.0002
828 GASTROENTERITIS VIRAL 3 0.0002
829 SKIN EXFOLIATION 14 0.0002
830 OSTEOMYELITIS 3 0.0002
831 APHASIA 5 0.0002
832 THERAPEUTIC RESPONSE DECREASED 10 0.0002
833 TREATMENT NONCOMPLIANCE 9 0.0002
834 UNDERDOSE 12 0.0002
835 PLEURAL EFFUSION 10 0.0002
836 DISCOMFORT 10 0.0002
837 ABASIA 4 0.0002
838 DEVICE DISLOCATION 7 0.0002
839 BACTERIAL INFECTION 3 0.0002
840 HEPATIC CIRRHOSIS 3 0.0002
841 BLOOD SODIUM DECREASED 3 0.0002
842 HAEMATEMESIS 4 0.0002
843 OVERDOSE 34 0.0002
844 HYPOPHAGIA 4 0.0002
845 ANOREXIA 2 0.0002
846 HERNIA 3 0.0002
847 DIPLOPIA 4 0.0002
848 BLOOD CREATININE INCREASED 10 0.0002
849 PSORIASIS 20 0.0002
850 SKIN IRRITATION 7 0.0002
851 ANHEDONIA 4 0.0002
852 WHEEZING 9 0.0002
853 DRUG INTERACTION 24 0.0002
854 BLOOD PRESSURE ABNORMAL 3 0.0002
855 ERYTHEMA 31 0.0002
856 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
857 VIRAL INFECTION 5 0.0002
858 RENAL DISORDER 7 0.0002
859 PREGNANCY 3 0.0001
860 TYPE 2 DIABETES MELLITUS 5 0.0001
861 FEEDING DISORDER 3 0.0001
862 CEREBROVASCULAR ACCIDENT 25 0.0001
863 INJURY ASSOCIATED WITH DEVICE 3 0.0001
864 BODY TEMPERATURE INCREASED 3 0.0001
865 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
866 AKATHISIA 2 0.0001
867 SKIN LESION 4 0.0001
868 HYPOGLYCAEMIA 7 0.0001
869 DIABETES MELLITUS 11 0.0001
870 DELIRIUM 5 0.0001
871 MENTAL STATUS CHANGES 4 0.0001
872 ATRIAL FIBRILLATION 14 0.0001
873 KNEE ARTHROPLASTY 3 0.0001
874 MOUTH ULCERATION 3 0.0001
875 DEVICE MALFUNCTION 10 0.0001
876 ASTHMA 16 0.0001
877 ADVERSE EVENT 13 0.0001
878 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
879 ANGINA PECTORIS 4 0.0001
880 CARDIAC FAILURE CONGESTIVE 11 0.0001
881 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
882 GLOSSODYNIA 3 0.0001
883 ECZEMA 7 0.0001
884 RESPIRATORY DISORDER 4 0.0001
885 PANCREATITIS 7 0.0001
886 CORONARY ARTERY DISEASE 4 0.0001
887 ILL-DEFINED DISORDER 8 0.0001
888 INFECTION 19 0.0001
889 NERVOUS SYSTEM DISORDER 4 0.0001
890 ANAPHYLACTIC REACTION 7 0.0001
891 PRODUCT PRESCRIBING ERROR 3 0.0001
892 RASH ERYTHEMATOUS 6 0.0001
893 MULTIPLE SCLEROSIS 6 0.0001
894 ABSCESS 2 0.0001
895 HEPATIC CANCER 3 0.0001
896 HYPOTENSION 25 0.0001
897 OXYGEN SATURATION DECREASED 7 0.0001
898 HAEMORRHAGE 13 0.0001
899 HYPONATRAEMIA 7 0.0001
900 LOCALISED INFECTION 3 0.0001
901 EXTRA DOSE ADMINISTERED 5 0.0001
902 LUNG DISORDER 6 0.0001
903 LUNG NEOPLASM MALIGNANT 5 0.0001
904 SEIZURE 14 0.0001
905 INFUSION RELATED REACTION 8 0.0001
906 PNEUMONIA ASPIRATION 3 0.0001
907 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
908 AGGRESSION 6 0.0001
909 HALLUCINATION 9 0.0001
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
911 THERAPY CESSATION 6 0.0001
912 HAEMATURIA 4 0.0001
913 DRUG RESISTANCE 3 0.0001
914 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
915 SKIN ULCER 3 0.0001
916 RASH GENERALISED 3 0.0001
917 STOMATITIS 7 0.0001
918 RESPIRATORY TRACT INFECTION 3 0.0001
919 SEDATION 3 0.0001
920 HYPOXIA 4 0.0001
921 EXPOSURE DURING PREGNANCY 7 0.0001
922 PULMONARY OEDEMA 5 0.0001
923 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
924 HAEMOPTYSIS 3 0.0001
925 PANCYTOPENIA 6 0.0001
926 WOUND 3 0.0001
927 HAEMOGLOBIN DECREASED 11 0.0001
928 ARRHYTHMIA 5 0.0001
929 COLITIS 4 0.0001
930 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
931 PLATELET COUNT DECREASED 11 0.0001
932 LIVER FUNCTION TEST ABNORMAL 3 0.0001
933 NEEDLE ISSUE 3 0.0001
934 PLASMA CELL MYELOMA 4 0.0001
935 TACHYCARDIA 9 0.0001
936 BLOOD GLUCOSE INCREASED 19 0.0001
937 ABORTION SPONTANEOUS 4 0.0001
938 ANAEMIA 19 0.0001
939 CELLULITIS 5 0.0001
940 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
941 PNEUMONIA 32 0.0001
942 BLINDNESS 4 0.0001
943 GYNAECOMASTIA 3 0.0001
944 CARDIAC ARREST 8 0.0001
945 COMPLETED SUICIDE 8 0.0001
946 DRUG-INDUCED LIVER INJURY 3 0.0001
947 BRADYCARDIA 5 0.0001
948 RENAL FAILURE ACUTE 4 0.0001
949 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
950 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
951 LIVER DISORDER 4 0.0001
952 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
953 EYE PRURITUS 3 0.0001
954 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
955 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
956 COMA 4 0.0001
957 RENAL IMPAIRMENT 7 0.0001
958 DRUG INTOLERANCE 8 0.0001
959 HYPERGLYCAEMIA 3 0.0001
960 PRODUCT STORAGE ERROR 7 0.0001
961 NO ADVERSE EVENT 14 0.0001
962 DISEASE PROGRESSION 9 0.0001
963 NEUTROPHIL COUNT DECREASED 3 0.0001
964 RHABDOMYOLYSIS 3 0.0001
965 CARDIO-RESPIRATORY ARREST 3 0.0001
966 DEVICE LEAKAGE 3 0.0001
967 SEPTIC SHOCK 3 0.0001
968 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
969 RESPIRATORY FAILURE 5 0.0001
970 ILLNESS 7 0.0001
971 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
972 SUICIDE ATTEMPT 4 0.0001
973 BLOOD GLUCOSE DECREASED 3 0.0001
974 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
976 HOSPITALISATION 9 0.0001
977 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
978 ACCIDENTAL OVERDOSE 2 0.0001
979 SEPSIS 6 0.0001
980 CARDIAC FAILURE 4 0.0000
981 ANGIOEDEMA 2 0.0000
982 NEOPLASM MALIGNANT 3 0.0000
983 PRODUCT DOSE OMISSION ISSUE 13 0.0000
984 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
985 DRUG DEPENDENCE 6 0.0000
986 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
987 TOXICITY TO VARIOUS AGENTS 6 0.0000
988 COVID-19 6 0.0000
989 DEATH 28 0.0000
990 NEUTROPENIA 3 0.0000